Detalhe da pesquisa
1.
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.
Int J Mol Sci
; 22(21)2021 Oct 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34769025
2.
Chronic Kidney Disease-Associated Inflammation Increases the Risks of Acute Kidney Injury and Mortality after Cardiac Surgery.
Int J Mol Sci
; 21(24)2020 Dec 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33353159
3.
Integrated miRNA/mRNA Counter-Expression Analysis Highlights Oxidative Stress-Related Genes CCR7 and FOXO1 as Blood Markers of Coronary Arterial Disease.
Int J Mol Sci
; 21(6)2020 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32178422
4.
ALUminating the Path of Atherosclerosis Progression: Chaos Theory Suggests a Role for Alu Repeats in the Development of Atherosclerotic Vascular Disease.
Int J Mol Sci
; 19(6)2018 06 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29895733
5.
Mechanisms regulating cell membrane localization of the chemokine receptor CXCR4 in human hepatocarcinoma cells.
Biochim Biophys Acta
; 1853(5): 1205-18, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25704914
6.
Overactivation of the TGF-ß pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.
Hepatology
; 58(6): 2032-44, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23813475
7.
MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport.
Biomed Pharmacother
; 146: 112596, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35062066
8.
Dynamic Variations of 3'UTR Length Reprogram the mRNA Regulatory Landscape.
Biomedicines
; 9(11)2021 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34829789
9.
In vivo CD40 Silencing by siRNA Infusion in Rodents and Evaluation by Kidney Immunostaining.
Bio Protoc
; 11(10): e4032, 2021 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34150939
10.
Unveiling ncRNA regulatory axes in atherosclerosis progression.
Clin Transl Med
; 9(1): 5, 2020 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32009226
11.
Progress in the Development and Challenges for the Use of Artificial Kidneys and Wearable Dialysis Devices.
Kidney Dis (Basel)
; 5(1): 3-10, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30815458
12.
The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE -/- mice.
J Inflamm (Lond)
; 16: 25, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31889910
13.
Datasets for the validation of the "in vivo" siRNA-silencing of CD40 and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice.
Data Brief
; 9: 1105-1112, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27924297
14.
Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
Atherosclerosis
; 255: 80-89, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27835742